Peer review reports
From: Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial
Original Submission |
1 Jul 2022 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
11 Jul 2022 |
Author responded |
Author comments - Alejandro Llanos-Cuentas
|
Resubmission - Version 3 |
11 Jul 2022 |
Submitted |
Manuscript version 3
|
Publishing |
30 Jan 2023 |
Editorially accepted |
|
28 Feb 2023 |
Article published |
10.1186/s13104-023-06281-7
|
Learn about peer review